Reported Q: Q2 2024 Rev YoY: +4.9% EPS YoY: +45.9% Move: -0.24%
ColgatePalmolive Company
CL
$93.93 -0.24%
Exchange NYSE Sector Consumer Defensive Industry Household Personal Products
Q2 2024
Published: Jul 26, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for CL

Reported

Report Date

Jul 26, 2024

Quarter Q2 2024

Revenue

5.06B

YoY: +4.9%

EPS

0.89

YoY: +45.9%

Market Move

-0.24%

Previous quarter: Q1 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $5.06B up 4.9% year-over-year
  • EPS of $0.89 increased by 45.9% from previous year
  • Gross margin of 60.7%
  • Net income of 731.00M
  • "“As part of our ambition to deliver consistent compounded earnings growth, we have talked about the importance of driving balanced organic sales growth - all six divisions, all four categories, and with a combination of volume and pricing growth.”" - Noel Wallace
CL
Company CL

Executive Summary

Colgate-Palmolive reported solid Q2 2024 results, with revenue of $5.058 billion, up 4.9% year over year and flat sequentially. The quarter featured meaningful margin expansion as volume re-accelerated across key brands, underpinning operating income of $1.159 billion (+18.9% YoY) and net income of $731 million (+45.6% YoY). Management framed the print as evidence of a successful transition to a volume-led growth model supported by investments in marketing, innovation, and capabilities across all six divisions and four product categories. The company continues to deploy data- and AI-enabled tools to optimize the ROI of higher marketing spend and to sustain balanced top-line growth through pricing where necessary. Notably, Hill’s Pet Nutrition delivered a meaningful margin inflection as leverage from higher volumes and the absence of excessive inflation aided profitability, while LatAm and Europe demonstrated robust performance through mix of volume gains and selective pricing actions. Colgate reiterated a disciplined capital-allocation stance, including a $480 million share repurchase in the quarter and a $473 million dividend payout, funded by $990 million of operating cash flow and $873 million of free cash flow.

Key Performance Indicators

Revenue
Increasing
5.06B
QoQ: -0.14% | YoY: 4.89%
Gross Profit
Increasing
3.07B
60.68% margin
QoQ: 1.09% | YoY: 10.12%
Operating Income
Increasing
1.16B
QoQ: 0.17% | YoY: 18.89%
Net Income
Increasing
731.00M
QoQ: 7.03% | YoY: 45.62%
EPS
Increasing
0.89
QoQ: 7.23% | YoY: 45.90%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 4,911.00 0.85 -3.0% View
Q4 2024 4,945.00 0.90 -0.1% View
Q3 2024 5,033.00 0.90 +2.4% View
Q2 2024 5,058.00 0.89 +4.9% View
Q1 2024 5,065.00 0.83 +6.2% View